Visudyne

Patient Assistance Services Are Available for VISUDYNE®

Bausch and Lomb is committed to helping eligible patients obtain affordable treatments*

FREE personalized patient assistance available through the Focus on Access (FOA) program offering*:

  • Reimbursement counseling on VISUDYNE®:
    • At your request, FOA counselors will see if the product prescribed is covered by your insurance
    • FOA counselors can also assist you with information concerning the prior authorization process, claim denials, and the appeals process
  • Eligibility for patient assistance for those without insurance coverage*
    • You may be eligible if you do not have insurance coverage
  • Eligibility to receive the product at no cost*
    • You may be eligible based on:
      • Lack of access to product prescribed
      • Documentation of household income
      • Proof of US residency

*Terms and Conditions Apply. Your doctor can refer you to the Focus on Access program to determine your eligibility for patient assistance.

For information on Reimbursement and Patient Assistance Services, Call the FOCUS ON ACCESS Hotline, (866) 272-8838 (Monday-Friday, 9 AM to 5 PM EST).

Enrollment Form

Download FOA Enrollment Form

FAQs About Coverage and Reimbursement*

What if you have insurance but the product is not covered?
  • If a claim is denied, an FOA counselor will assist you with information concerning the claim-appeal process
  • You may also be considered for the Patient Assistance Program
What if you are still without insurance after 1 year?
  • Continued assistance may be provided after you reapply to the program and you meet the pre-established eligibility criteria*
  • In order to be considered for continued assistance, you must submit an application every 12 months*
How can I get started?
  • You need to fill out the Patient Information section of the FOA enrollment form
  • Your doctor will provide you with this form
  • The form will instruct you what information you need to supply
  • Submit your filled out enrollment form with the necessary documents by mail or fax to:

    FOCUS ON ACCESS PROGRAM
    PO Box 220662
    Charlotte, NC 28222-0662
    FAX: (866) 272-8839

Please note: Faxed enrollment forms are acceptable

*Terms and Conditions Apply. Your doctor can refer you to the Focus on Access program to determine your eligibility for patient assistance.

Indication

VISUDYNE® (verteporfin for injection) is used along with laser light treatment to stop leaking from blood vessels in the eye due to the following serious eye conditions: age-related macular degeneration (a condition affecting the retina of the eye which can impair vision), pathologic myopia (extreme nearsightedness) or ocular histoplasmosis (a certain type of fungus infection in the eye).

Important Safety Information

  • VISUDYNE® (verteporfin for injection) should not be used if you have a condition known as porphyria, or if you are allergic to it or any of its components.
  • Avoid exposure of skin and eyes to direct sunlight or bright indoor light for 5 days after treatment with VISUDYNE® by wearing protective clothes and dark sunglasses. A UV sunscreen will not offer enough protection for your skin. Wear a wristband to remind you to do this. However, do not stay in totally dark areas. You should expose your skin to regular indoor and/or indirect light because doing so will help inactivate the drug in your skin.
  • In clinical studies, the most common side effects were injection site reactions (such as pain, redness, irritation, and swelling) or changes in vision (including blurred vision and flashes of light). Tell your doctor about any side effects that you may have.
  • Do not drive or use machines if you develop or have changes in vision.

You are encouraged to report side effects to the FDA. To report SUSPECTED ADVERSE REACTIONS, contact Bausch + Lomb, a division of Valeant Pharmaceuticals North America LLC, at 1‑800‑321‑4576 or FDA at 1‑800‑FDA‑1088 or www.fda.gov/medwatch.

Please click here for full Prescribing Information for VISUDYNE®.

Indication and Important Safety Information